Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9605 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9539 |
High Similarity |
NPD1934 |
Approved |
0.9308 |
High Similarity |
NPD6166 |
Phase 2 |
0.9308 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9308 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9198 |
High Similarity |
NPD7074 |
Phase 3 |
0.9136 |
High Similarity |
NPD7054 |
Approved |
0.9103 |
High Similarity |
NPD2801 |
Approved |
0.908 |
High Similarity |
NPD7472 |
Approved |
0.9032 |
High Similarity |
NPD4380 |
Phase 2 |
0.8957 |
High Similarity |
NPD3818 |
Discontinued |
0.8931 |
High Similarity |
NPD7075 |
Discontinued |
0.8889 |
High Similarity |
NPD1511 |
Approved |
0.8868 |
High Similarity |
NPD3882 |
Suspended |
0.8855 |
High Similarity |
NPD7251 |
Discontinued |
0.8805 |
High Similarity |
NPD3817 |
Phase 2 |
0.8802 |
High Similarity |
NPD7808 |
Phase 3 |
0.8795 |
High Similarity |
NPD6797 |
Phase 2 |
0.8774 |
High Similarity |
NPD1512 |
Approved |
0.875 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.871 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8704 |
High Similarity |
NPD5494 |
Approved |
0.8696 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.869 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8688 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8625 |
High Similarity |
NPD7819 |
Suspended |
0.8618 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8618 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD6801 |
Discontinued |
0.8562 |
High Similarity |
NPD1549 |
Phase 2 |
0.8554 |
High Similarity |
NPD7473 |
Discontinued |
0.8485 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8424 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8412 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8385 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8353 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8247 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8224 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8171 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8105 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8059 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8025 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7988 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7987 |
Intermediate Similarity |
NPD943 |
Approved |
0.7976 |
Intermediate Similarity |
NPD919 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7889 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.788 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7809 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7791 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7791 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7759 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7758 |
Intermediate Similarity |
NPD1653 |
Approved |
0.775 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7736 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7716 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7707 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7706 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7697 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7697 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7684 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7679 |
Intermediate Similarity |
NPD37 |
Approved |
0.7657 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD7584 |
Approved |
0.763 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7595 |
Intermediate Similarity |
NPD447 |
Suspended |
0.759 |
Intermediate Similarity |
NPD920 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD6777 |
Approved |
0.75 |
Intermediate Similarity |
NPD6780 |
Approved |
0.75 |
Intermediate Similarity |
NPD6778 |
Approved |
0.75 |
Intermediate Similarity |
NPD6776 |
Approved |
0.75 |
Intermediate Similarity |
NPD6779 |
Approved |
0.75 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7461 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7427 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7385 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7382 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7382 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7382 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7346 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD5710 |
Approved |
0.733 |
Intermediate Similarity |
NPD5711 |
Approved |
0.732 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7245 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7245 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7238 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7232 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7231 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7211 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7196 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.711 |
Intermediate Similarity |
NPD6386 |
Approved |
0.711 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7107 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7081 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7077
|
Intermediate Similarity |
NPD8320 |
Phase 1 |